A Registry Following Adults With Early Lung Cancer Who Have Lung Surgery
Collects patient questionnaires before and after segmentectomy surgery for early lung cancer.
Plain-language title generated from the registry record
Registry title: A Registry for People With Lung Cancer
Key facts
- Where
- Montreal and Toronto, CanadaSee the 2 sites
Where in Canada
- Centre Hospitalier de l'Université de Montreal (Data Collection Only)Montreal, CanadaTaking people
- University Health Network (Data Collection Only)Toronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Memorial Sloan Kettering Cancer Center
- Trial code
- NCT06424327
- Record updated
- 24 September 2026
- Original description
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.Read full original descriptionShow less
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Inclusion: Age ≥18 years; Patients suitable for segmentectomy, according to the treating surgeon; Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology.
Exclusion: Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years; History of chemotherapy or radiation therapy for a previous lung cancer; Actively receiving treatment for other malignancies; Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis; Multi-segmental resection from the same lobe is not a criterion for exclusion; Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery; History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix; Carcinoid tumors.